SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-001610
Filing Date
2024-03-22
Accepted
2024-03-22 08:51:56
Documents
16
Period of Report
2024-03-18
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cnbx_8k.htm   iXBRL 8-K 26297
2 LETTER FROM IDAN WEINSTEIN cnbx_ex1601.htm EX-16.1 1966
6 GRAPHIC image_004.jpg GRAPHIC 2919
7 GRAPHIC image_005.jpg GRAPHIC 7964
  Complete submission text file 0001683168-24-001610.txt   212448

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cnbx-20240318.xsd EX-101.SCH 3286
4 XBRL LABEL FILE cnbx-20240318_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cnbx-20240318_pre.xml EX-101.PRE 22361
19 EXTRACTED XBRL INSTANCE DOCUMENT cnbx_8k_htm.xml XML 3357
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
CNBX Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52403 | Film No.: 24773247
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)